Update on Glaxo’s Contracts

http://genericpharmalitigator.com/wp-content/uploads/2013/09/wpid-curata__lXKizH7mbw3OBoM.jpeg

GlaxoSmithKline (GSK) has several contracts in its kitty to supply products including antibiotics, cephalosporins and penicillins to contract manufacturing partners. The Biomedical Advanced Research and Development Authority (BARDA), a part of the U.S. Department of Health and Human Services (HHS), has entered into a four-year contract with Glaxo to purchase raxibacumab for combating a potential bioterrorist attack.

Read the source article at Zacks Investment Research